|
1
|
Hallek M: Chronic lymphocytic leukemia:
2013 update on diagnosis, risk stratification and treatment. Am J
Hematol. 88:803–816. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jaffe ES, Harris NL, Stein H, Campo E,
Pileri SA and Swerdlow SH: Introduction and overview of the
classification of the lymphoid neoplasmsWHO Classification of
Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo
E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thilele J and Vardiman
JW: 2. 4th. IARC Press; Lyon: pp. 158–166. 2008
|
|
3
|
Xu W, Li JY, Pan JL, Qiu HR, Shen YF, Li
L, Wu YF and Xue YQ: Interphase fluorescence in situ
hybridization detection of cytogenetic abnormalities in B-cell
chronic lymphocytic leukemia. Int J Hematol. 85:430–436. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Put N, Meeus P, Chatelain B, Rack K,
Boeckx N, Nollet F, Graux C, Van Den Neste E, Janssens A, et al:
Translocation t(14;18) is not associated with inferior outcome in
chronic lymphocytic leukemia. Leukemia. 23:1201–1204. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lu G, Kong Y and Yue C: Genetic and
immunophenotypic profile of IGH@ rearrangement detected by
fluorescence in situ hybridization in 149 cases of B-cell
chronic lymphocytic leukemia. Cancer Genet Cytogenet. 196:56–63.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baseggio L, Geay MO, Gazzo S, Berger F,
Traverse-Glehen A, Ffrench M, Hayette S, Callet-Bauchu E, Verney A,
Morel D, et al: In non-follicular lymphoproliferative disorders,
IGH/BCL2-fusion is not restricted to chronic lymphocytic leukaemia.
Br J Haematol. 158:489–498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang F, Yan LX, Lin SX, Ye ZY, Zhuang HG,
Yun JP, Lin HL, Luo DL, Xu FP, Luo XL, et al: Immunophenotypic
features and t(14;18) (q32;q21) translocation of Chinese follicular
lymphomas helps to distinguish subgroups. Diagn Pathol. 8:1542013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schüler F, Dölken L, Hirt C, Kiefer T,
Berg T, Fusch G, Weitmann K, Hoffmann W, Fusch C, Janz S, et al:
Prevalence and frequency of circulating t(14;18)-MBR translocation
carrying cells in healthy individuals. Int J Cancer. 124:958–963.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Haferlach C, Dicker F, Schnittger S, Kern
W and Haferlach T: Comprehensive genetic characterization of CLL: A
study on 506 cases analysed with chromosome banding analysis,
interphase FISH, IgV(H) status and immunophenotyping. Leukemia.
21:2442–2451. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Amare PS, Gadage V, Jain H, Nikalje S,
Manju S, Mittal N, Gujral S and Nair R: Clinico-pathological impact
of cytogenetic subgroups in B-cell chronic lymphocytic leukemia:
Experience from India. Indian J Cancer. 50:261–267. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sen F, Lai R and Albitar M: Chronic
lymphocytic leukemia with t(14;18) and trisomy 12. Arch Pathol Lab
Med. 126:1543–1546. 2002.PubMed/NCBI
|
|
12
|
Kern W, Haferlach T, Schnittger S and
Schoch C: Detection of t(14;18)(q32;q21) in B-cell chronic
lymphocytic leukemia. Arch Pathol Lab Med. 129:410–411.
2005.PubMed/NCBI
|
|
13
|
Kojima K, Taniwaki M, Yoshino T, Katayama
Y, Sunami K, Fukuda S, Omoto E, Harada M and Sezaki T: Trisomy 12
and t(14;18) in B-cell chronic lymphocytic leukemia. Int J Hematol.
67:199–203. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jonveaux P, Hillion J, Bennaceur AL,
d'Agay MF, Brice P, Daniel MT, Sigaux F and Berger R: t(14;18) and
bcl-2 gene rearrangement in a B-chronic lymphocytic leukaemia. Br J
Haematol. 81:620–621. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dong HJ, Zhou LT, Zhu DX, Wang DM, Fang C,
Zhu HY, Zhuang Y, Miao KR, Xu W and Li JY: The prognostic
significance of TP53 mutations in Chinese patients with chronic
lymphocytic leukemia is independent of del(17p13). Ann Hematol.
90:709–717. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sekiguchi Y, Imai H, Wakabayashi M, Sawada
T, Ichikawa K, Komatsu N and Noguchi M: CD5-positive follicular
lymphoma: A case report and literature review. Intern Med.
50:899–904. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oscier D, Dearden C, Eren E, Fegan C,
Follows G, Hillmen P, Illidge T, Matutes E, Milligan DW, Pettitt A,
et al: British Committee for Standards in Haematology: Guidelines
on the diagnosis, investigation and management of chronic
lymphocytic leukaemia. Br J Haematol. 159:541–564. 2012.PubMed/NCBI
|
|
18
|
Juliusson G, Oscier DG, Fitchett M, Ross
FM, Stockdill G, Mackie MJ, Parker AC, Castoldi GL, Guneo A,
Knuutila S, et al: Prognostic subgroups in B-cell chronic
lymphocytic leukemia defined by specific chromosomal abnormalities.
N Engl J Med. 323:720–724. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang G, Banks HE, Sargent RL, Medeiros LJ
and Abruzzo LV: Chronic lymphocytic leukemia with
t(14;18)(q32;q21). Hum Pathol. 44:598–605. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matutes E, Oscier D, Garcia-Marco J, Ellis
J, Copplestone A, Gillingham R, Hamblin T, Lens D, Swansbury GJ and
Catovsky D: Trisomy 12 defines a group of CLL with atypical
morphology: Correlation between cytogenetic, clinical and
laboratory features in 544 patients. Br J Haematol. 92:382–388.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mayr C, Speicher MR, Kofler DM, Buhmann R,
Strehl J, Busch R, Hallek M and Wendtner CM: Chromosomal
translocations are associated with poor prognosis in chronic
lymphocytic leukemia. Blood. 107:742–751. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Damle RN, Wasil T, Fais F, Ghiotto F,
Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J,
et al: Ig V gene mutation status and CD38 expression as novel
prognostic indicators in chronic lymphocytic leukemia. Blood.
94:1840–1847. 1999.PubMed/NCBI
|
|
23
|
Mauerer K, Zahrieh D, Gorgun G, Li A, Zhou
J, Ansén S, Rassenti LZ and Gribben JG: Immunoglobulin gene segment
usage, location and immunogenicity in mutated and unmutated chronic
lymphocytic leukaemia. Br J Haematol. 129:499–510. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hamblin TJ, Davis Z, Gardiner A, Oscier DG
and Stevenson FK: Unmutated Ig V(H) genes are associated with a
more aggressive form of chronic lymphocytic leukemia. Blood.
94:1848–1854. 1999.PubMed/NCBI
|
|
25
|
Shanafelt TD, Witzig TE, Fink SR, Jenkins
RB, Paternoster SF, Smoley SA, Stockero KJ, Nast DM, Flynn HC,
Tschumper RC, et al: Prospective evaluation of clonal evolution
during long-term follow-up of patients with untreated early-stage
chronic lymphocytic leukemia. J Clin Oncol. 24:4634–4641. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smolewski P, Witkowska M and
Korycka-Wołowiec A: New insights into biology, prognostic factors,
and current therapeutic strategies in chronic lymphocytic leukemia.
ISRN Oncol. 2013:7406152013.PubMed/NCBI
|
|
27
|
Cavazzini F, Hernandez JA, Gozzetti A,
Russo Rossi A, De Angeli C, Tiseo R, Bardi A, Tammiso E, Crupi R,
Lenoci MP, et al: Chromosome 14q32 translocations involving the
immunoglobulin heavy chain locus in chronic lymphocytic leukaemia
identify a disease subset with poor prognosis. Br J Haematol.
142:529–537. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nowakowski GS, Dewald GW, Hoyer JD,
Paternoster SF, Stockero KJ, Fink SR, Smoley SA, Remstein ED,
Phyliky RL, Call TG, et al: Interphase fluorescence in situ
hybridization with an IGH probe is important in the evaluation of
patients with a clinical diagnosis of chronic lymphocytic
leukaemia. Br J Haematol. 130:36–42. 2005. View Article : Google Scholar : PubMed/NCBI
|
